WATCHMAN Education Specialists are trained professionals with healthcare experience. They're here to help answer your questions.
Already took the quiz? Return to your personalized experience.
Leave blood thinners behind
AFib doesn't have to mean a lifetime of risk and worry about the side effects of blood thinners. The WATCHMAN Implant is a safe, minimally invasive, one-time implant for people with non-valvular atrial fibrillation (AFib) that reduces your stroke risk – without the need for lifelong blood thinners. In a clinical trial, 96% of people were able to stop their blood thinners 45 days after getting the WATCHMAN Implant.1
There are risks associated with all medical procedures. Please talk with your doctor about the risks and benefits of the WATCHMAN Implant.
The WATCHMAN Implant device reduces the risk of stroke from non‑valvular AFib
Blood thinners aren't the only option to reduce AFib stroke risk. The WATCHMAN Implant is the most implanted FDA-approved device proven to reduce stroke risk in people with atrial fibrillation not caused by a heart valve problem. Watch the video to learn more and talk to your doctor about the WATCHMAN Implant.
Over half a million people have left blood thinners behind with the WATCHMAN Implant
Real WATCHMAN Ambassador stories
Meet people living free from worrying about stroke risk and serious bleeding events – thanks to the WATCHMAN Implant.
MEET CAROLE
“I’m so much more relaxed about enjoying things I want to do.”
Since receiving the WATCHMAN Implant, Carole enjoys traveling without fear of bleeding.
MEET WAYNE
“The risk of blood thinners versus WATCHMAN? It was a no-brainer.”
After getting his WATCHMAN Implant procedure, Wayne’s back to yoga, hiking and volunteering – all without the worries of bleeding or fear of stroke.
Keep exploring
“We are people living with AFib.”
An introduction to the population of 500,000+ people who've left blood thinners behind and said goodbye to their bleeding worry – for life.
Have questions about the WATCHMAN Implant?
Monday to Friday, 8 a.m. to 5 p.m. CT
*In a clinical trial, 96% of patients were able to discontinue their blood thinner 45 days after getting the WATCHMAN Implant.
References:
1. Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
Content on this web page is for Informational Purposes only and does not constitute medical advice and should not be used for medical diagnoses. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any clinical/medical questions.
Important Safety Information
The WATCHMAN FLX and WATCHMAN FLX Pro Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke.
With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks include but are not limited to accidental heart puncture, air embolism, allergic reaction, anemia, anesthesia risks, arrhythmias, AV (Arteriovenous) fistula, bleeding or throat pain from the TEE (Trans Esophageal Echo) probe, blood clot or air bubbles in the lungs or other organs, bruising at the catheter insertion site, clot formation on the device, cranial bleed, excessive bleeding, gastrointestinal bleeding, groin puncture bleed, hypotension, infection/pneumonia, pneumothorax, pulmonary edema, pulmonary vein obstruction, renal failure, stroke, thrombosis and transient ischemic attack. In rare cases death can occur.
Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the device.